The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Regulating Off-Label Drug Use — Rethinking the Role of the FDA
Open accessAbstract
Off-label prescribing is legal and common, but it is often done in the absence of adequate supporting data. Dr. Randall Stafford writes that although there is a strong rationale for greater FDA involvement in off-label use, it is moving toward relinquishing control in its new draft guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Off-label prescribing among office-based physicians
Radley, D. C., Finkelstein, S. N., & Stafford, R. S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.9.1021 · Cited by 711
National Trends in Cyclooxygenase-2 Inhibitor Use Since Market Release
Dai, C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.2.171 · Cited by 110
Cited by
Ten common questions (and their answers) about off-label drug use
Wittich, C. M., Burkle, C. M., & Lanier, W. L. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.04.017 · Cited by 368
Diagnosis, Assessment, and Treatment of Hypersexuality
Kaplan, M. S., & Krueger, R. B. (2010) · The Journal of Sex Research · doi:10.1080/00224491003592863 · Cited by 267
Association of Off-label Drug Use and Adverse Drug Events in an Adult Population
Eguale, T., Buckeridge, D. L., Verma, A., Winslade, N. E., Benedetti, A., Hanley, J. A., & Tamblyn, R. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.6058 · Cited by 262
Complications due to the use of BMP/INFUSE in spine surgery: The evidence continues to mount
Epstein, N. (2013) · Surgical Neurology International · doi:10.4103/2152-7806.114813 · Cited by 252
Wong, J., Motulsky, A., Abrahamowicz, M., Eguale, T., Buckeridge, D. L., & Tamblyn, R. (2017) · BMJ · doi:10.1136/bmj.j603 · Cited by 221
Metadata
- Authors
- Stafford, R. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-04-03
- Volume
- 358
- Issue
- 14
- Pages
- 1427-1429
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1997101969
- Cited by
- 350
- References
- 2
- FWCI
- 20.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulating Off-Label Drug Use — Rethinking the Role of the FDA. https://app.cochat.ai/papers/10.1056/nejmp0802107
- The paper
- Stafford, R. S. (2008). Regulating Off-Label Drug Use — Rethinking the Role of the FDA. New England Journal of Medicine. https://doi.org/10.1056/nejmp0802107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.